Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Biomarin Pharmaceutical Inc (NASDAQ:BMRN)

82.71
Delayed Data
As of 12:31pm ET
 -2.38 / -2.80%
Today’s Change
62.12
Today|||52-Week Range
151.75
-21.05%
Year-to-Date

Today’s Trading

Previous close85.09
Today’s open84.15
Day’s range81.95 - 84.74
Volume702,349
Average volume (3 months)1,791,152
Market cap$14.1B
Dividend yield--
Data as of 12:31pm ET, 05/04/2016

Growth & Valuation

Earnings growth (last year)-16.30%
Earnings growth (this year)-107.42%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+16.29%
P/E ratioNM
Price/Sales19.22
Price/Book5.85

Competitors

 Today’s
change
Today’s
% change
INCYIncyte Corp-2.78-3.86%
PRGOPerrigo Company PLC-1.17-1.21%
VRXValeant Pharmaceutic...-1.74-4.86%
MDVNMedivation Inc+1.55+2.69%
Data as of 12:46pm ET, 05/04/2016

Financials

Next reporting dateJuly 27, 2016
EPS forecast (this quarter)-$0.55
Annual revenue (last year)$872.2M
Annual profit (last year)-$171.8M
Net profit margin-19.70%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Jean-Jacques Bienaimé
Chief Financial Officer &
Executive Vice President
Daniel K. Spiegelman
Corporate headquarters
San Rafael, California

Forecasts

Partner Offers

Search for Jobs